glp-1's GLP-1 GLP-1 Agonists: A Comprehensive Overview
Description
About half (54%) of those who report ever taking the drugs say it was difficult to afford them, including one in five (22%) who say it was very difficult. Having insurance coverage makes little difference to patients perceptions of the drugs affordability, with similar shares of those covered by insurance saying the drugs were difficult (53%) or very difficult (23%) to afford
Disproportionality analysis identified 19 GLP-1 RA-related NAEs using the ROR method
doi: 10.1089/dia.2011.0050 [DOI] [PMC free article] [PubMed] [Google Scholar] 90
In CD11b + CD11c + cell lines, Sterling and colleagues [73] showed conditions of glaucoma increased retinal inflammation and astrogliosis
doi:10.1016/j.addr.2018.07.009 6
